Protective Effects of Laser-Irradiated Streptococcus pneumoniae: A Novel Vaccine Candidate
محل انتشار: مجله تحقیق در پزشکی مولکولی، دوره: 13، شماره: 4
سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 2
فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_REMJ-13-4_004
تاریخ نمایه سازی: 22 مهر 1405
چکیده مقاله:
Streptococcus pneumoniae (S. pneumoniae) is a significant cause of community-acquired pneumonia worldwide. Pneumococcal vaccines can prevent severe disease; however, their high cost, limited serotype coverage, and variable effectiveness across populations underscore the need for alternative vaccine strategies. Laser irradiation has been proposed as a novel approach to attenuate bacterial virulence while preserving immunogenicity.
Clinical isolates of S. pneumoniae were irradiated using low‑energy laser irradiation at wavelengths of ۶۶۰ nm, ۸۲۰ nm, and ۹۱۵ nm to prepare an inactivated bacterial vaccine. Sterility testing confirmed complete bacterial inactivation. BALB/c mice were immunized three times at two-week intervals and were then challenged with wild-type S. pneumoniae. A commercial pneumococcal vaccine served as a positive control. Antibody responses (immunoglobulin M [IgM], IgG, and IgA) were measured, and survival was monitored for ۲۱ days post-challenge.
Irradiation at ۹۱۵ nm was the most effective for bacterial inactivation. Mice immunized with the ۹۱۵ nm-inactivated vaccine showed significantly higher levels of IgM, IgG, and IgA compared to the unvaccinated group. Following bacterial challenge, all mice in this group survived, whereas ۴۰% of mice immunized with the commercial vaccine died within ۲۱ days after challenge.
Low-energy laser irradiation at ۹۱۵ nm effectively inactivated S. pneumoniae while retaining its immunogenic properties. Immunization with this preparation elicited robust antibody responses and provided complete protection in mice, suggesting that it may serve as a novel pneumococcal vaccine candidate.
کلیدواژه ها:
نویسندگان
Nabeel Khudhair Hassoon
Department of Cell and Molecular Biology & Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran.
Mohammad Rabbani Khorasgani
Department of Cell and Molecular Biology & Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran.
Ihsan F. Rostum
College of Cosmetic & Laser Techniques, Cordoba Private University, Al- Najaf Al- Ashraf - Iraq.
Babak Beikzadeh
Department of Cell and Molecular Biology & Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran.
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :